Tevogen Bio Holdings Inc. — Director's Dealing 2025

Mar 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tevogen Bio Holdings Inc. (TVGN)
CIK: 0001860871
Period of Report: 2025-03-07

Reporting Person: Flomenberg Neal (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-07	Common Stock	S	71273	$1.14	Disposed	3969212	Direct
2025-03-10	Common Stock	S	70384	$1.09	Disposed	3898828	Direct
2025-03-11	Common Stock	S	70252	$1.05	Disposed	3828576	Direct

Footnotes

F1: The sales reported on this Form 4 were made solely to satisfy the payment of tax obligations relating to the vesting and subsequent settlement of restricted stock units. Such sales were not made at the discretion of the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (5) to this Form 4.

F3: These shares were sold in multiple transactions at prices ranging from $1.065 to $1.185, inclusive.

F4: These shares were sold in multiple transactions at prices ranging from $1.05 to $1.14, inclusive.

F5: These shares were sold in multiple transactions at prices ranging from $1.02 to $1.085, inclusive.